{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:21:51Z","timestamp":1788898911759,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00261-018-1498-z","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T17:23:13Z","timestamp":1519147393000},"page":"2446-2454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Percutaneous microwave ablation for local control of metastatic renal cell carcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Kimberly A.","family":"Maciolek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jason","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Emamekhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Averill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Ziemlewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan G.","family":"Lubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Louis","family":"Hinshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Fred T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"issue":"2","key":"1498_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1470-2045(12)70559-4","volume":"14","author":"DY Heng","year":"2013","unstructured":"Heng DY, Xie W, Regan MM, et al. (2013) External validation and comparison with other models of the international metastatic renal-cell carcinoma database consortium prognostic model: a population-based study. Lancet Oncol 14(2):141\u2013148","journal-title":"Lancet Oncol"},{"issue":"2","key":"1498_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/annonc\/mdl371","volume":"18","author":"TK Choueiri","year":"2007","unstructured":"Choueiri TK, Rini BI, Garcia JA, et al. (2007) Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma. Ann Oncol 18(2):249\u2013255","journal-title":"Ann Oncol"},{"key":"1498_CR3","unstructured":"National Cancer Institute (2014) SEER cancer stat facts: kidney and renal pelvis cancer. Bethesda, MD: National Cancer Institute."},{"issue":"2","key":"1498_CR4","doi-asserted-by":"publisher","first-page":"E93","DOI":"10.1016\/j.clgc.2014.08.013","volume":"13","author":"DM Geynisman","year":"2015","unstructured":"Geynisman DM, Hu JC, Liu L, Tina Shih YC (2015) Treatment patterns and drug costs for patients with metastatic renal cell carcinoma in the United States. Clin Genitourin Cancer 13(2):E93\u2013E100","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"1498_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jnci\/djr511","volume":"104","author":"T Eisen","year":"2012","unstructured":"Eisen T, Sternberg CN, Robert C, et al. (2012) Targeted therapies for renal cell carcinoma: review of adverse event management strategies. J Natl Cancer Inst 104(2):93\u2013113","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1498_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.hoc.2011.05.002","volume":"25","author":"JA Karam","year":"2011","unstructured":"Karam JA, Wood CG (2011) The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy. Hematol Oncol Clin N Am 25(4):753\u2013764","journal-title":"Hematol Oncol Clin N Am"},{"issue":"3","key":"1498_CR7","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/cncr.25836","volume":"117","author":"AL Alt","year":"2011","unstructured":"Alt AL, Boorjian SA, Lohse CM, et al. (2011) Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 117(3):2873\u20132882","journal-title":"Cancer"},{"issue":"12","key":"1498_CR8","doi-asserted-by":"publisher","first-page":"E549","DOI":"10.1016\/S1470-2045(14)70235-9","volume":"15","author":"S Dabestani","year":"2014","unstructured":"Dabestani S, Marconi L, Hofmann F, et al. (2014) Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol 15(12):E549\u2013E561","journal-title":"Lancet Oncol"},{"issue":"5","key":"1498_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljungberg","year":"2015","unstructured":"Ljungberg B, Bensalah K, Canfield S, et al. (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913\u2013924","journal-title":"Eur Urol"},{"issue":"2","key":"1498_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.eururo.2017.03.005","volume":"72","author":"CP Meyer","year":"2017","unstructured":"Meyer CP, Sun M, Karam JA, et al. (2017) Complications after metastasectomy for renal cell carcinoma: a population-based assessment. Eur Urol 72(2):171\u2013174","journal-title":"Eur Urol"},{"key":"1498_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.eururo.2014.07.021","volume":"2","author":"RH Thompson","year":"2015","unstructured":"Thompson RH, Atwell T, Schmit G, et al. (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2:252\u2013259","journal-title":"Eur Urol"},{"issue":"1","key":"1498_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1148\/radiol.2016160592","volume":"284","author":"ME Klapperich","year":"2017","unstructured":"Klapperich ME, Abel EJ, Ziemlewicz TJ, et al. (2017) Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage T1a renal cell carcinoma: a single-center, retrospective study. Radiology 284(1):272\u2013280","journal-title":"Radiology"},{"issue":"6","key":"1498_CR13","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00261-016-0776-x","volume":"41","author":"SA Wells","year":"2016","unstructured":"Wells SA, Wheeler KM, Mithqal A, et al. (2016) Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single-session treatment. Abdom Radiol 41(6):1203\u20131211","journal-title":"Abdom Radiol"},{"issue":"6","key":"1498_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et al. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649\u2013655","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"1498_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Alex KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"key":"1498_CR16","volume-title":"AJCC cancer staging manual","author":"SBBD Edge","year":"2010","unstructured":"Edge SBBD, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual, 7th edn. New York: Springer","edition":"7"},{"issue":"2","key":"1498_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205\u2013213","journal-title":"Ann Surg"},{"issue":"11","key":"1498_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jvir.2014.08.027","volume":"25","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL, et al. (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria\u2013a 10-year update. J Vasc Interv Radiol 25(11):1691\u20131705","journal-title":"J Vasc Interv Radiol"},{"key":"1498_CR19","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1200\/JCO.1998.16.6.2261","volume":"16","author":"JP Kavolius","year":"1998","unstructured":"Kavolius JP, Mastorakos DP, Pavlovich C, et al. (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16:2261\u20132266","journal-title":"J Clin Oncol"},{"key":"1498_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejcts.2010.05.021","volume":"39","author":"R Kanzaki","year":"2011","unstructured":"Kanzaki R, Higashiyma M, Fujiwara A, et al. (2011) Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience. Eur J Cardiothorac Surg 39:167\u2013172","journal-title":"Eur J Cardiothorac Surg"},{"key":"1498_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00345-010-0560-4","volume":"28","author":"MD Staehler","year":"2010","unstructured":"Staehler MD, Kruse J, Haseke N, et al. (2010) Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 28:543\u2013547","journal-title":"World J Urol"},{"key":"1498_CR22","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0003-4975(01)03602-5","volume":"73","author":"S Piltz","year":"2002","unstructured":"Piltz S, Meimarakis G, Wichmann MW, et al. (2002) Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73:1082\u20131087","journal-title":"Ann Thorac Surg"},{"issue":"2C","key":"1498_CR23","first-page":"1593","volume":"19","author":"G Friedel","year":"1999","unstructured":"Friedel G, Hurtgen M, Penzenstadler M, Kyriss T, Toomes H (1999) Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res 19(2C):1593\u20131596","journal-title":"Anticancer Res"},{"issue":"1","key":"1498_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1010-7940(96)01013-5","volume":"11","author":"P Fourquier","year":"1997","unstructured":"Fourquier P, Regnard JF, Rea S, Levi JF, Levasseur P (1997) Lung metastases of renal cell carcinoma: results of surgical resection. Eur J Cardiothorac Surg 11(1):17\u201321","journal-title":"Eur J Cardiothorac Surg"},{"key":"1498_CR25","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1097\/01.ju.0000177487.64651.3a","volume":"17","author":"BC Leibovich","year":"2005","unstructured":"Leibovich BC, Cheville JC, Lohse CM, et al. (2005) A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 17:1759\u20131763","journal-title":"J Urol"},{"key":"1498_CR26","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/cncr.11851","volume":"12","author":"BC Leibovich","year":"2003","unstructured":"Leibovich BC, Han KR, Bui MH, et al. (2003) Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 12:2566\u20132575","journal-title":"Cancer"},{"key":"1498_CR27","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1016\/j.jvir.2010.04.007","volume":"8","author":"MG Lubner","year":"2010","unstructured":"Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr (2010) Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 8:S192\u2013S203","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"1498_CR28","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jvir.2015.02.010","volume":"26","author":"TD Atwell","year":"2015","unstructured":"Atwell TD, Vlaminck JJ, Boorjian SA, et al. (2015) Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J Vasc Interv Radiol 26(6):792\u2013799","journal-title":"J Vasc Interv Radiol"},{"key":"1498_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jvir.2014.09.012","volume":"1","author":"TJ Ziemlewicz","year":"2015","unstructured":"Ziemlewicz TJ, Hinshaw JL, Lubner MG, et al. (2015) Percutaneous microwave ablation of hepatocellular carcinoma with a gas-cooled system: initial clinical results with 107 tumors. J Vasc Interv Radiol 1:62\u201368","journal-title":"J Vasc Interv Radiol"},{"key":"1498_CR30","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jvir.2016.01.001","volume":"4","author":"Y Egashira","year":"2016","unstructured":"Egashira Y, Singh S, Bandula S, Illing R (2016) Percutaneous high-energy microwave ablation for the treatment of pulmonary tumors: a retrospective single-center experience. J Vasc Interv Radiol 4:474\u2013479","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"1498_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.juro.2014.03.006","volume":"192","author":"BT Welch","year":"2014","unstructured":"Welch BT, Callstrom MR, Morris JM, et al. (2014) Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol 192(2):357\u2013363","journal-title":"J Urol"},{"issue":"6","key":"1498_CR32","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1464-410X.2009.08459.x","volume":"104","author":"N Soga","year":"2009","unstructured":"Soga N, Yamakado K, Gohara H, et al. (2009) Percutaneous radiofrequency ablation of unresectable pulmonary metastases from renal cell carcinoma. BJU Int 104(6):790\u2013794","journal-title":"BJU Int"},{"issue":"3","key":"1498_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1148\/radiol.2513081564","volume":"251","author":"CL Brace","year":"2009","unstructured":"Brace CL, Hinshaw JL, Laeseke PF, Sampson LA, Lee FT Jr (2009) Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology 251(3):705\u2013711","journal-title":"Radiology"},{"issue":"8","key":"1498_CR34","doi-asserted-by":"publisher","first-page":"529.e9","DOI":"10.1016\/j.urolonc.2017.03.009","volume":"35","author":"LFM Zanden van der","year":"2017","unstructured":"van der Zanden LFM, Vermeulen SH, Oskarsdottir A, et al. (2017) Description of the EuroTARGET cohort: an European collaborative project on targeted therapy in renal cell cancer genetic and tumor-related biomarkers for response and toxicity. Urol Oncol 35(8):529.e9\u2013529.e16","journal-title":"Urol Oncol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-018-1498-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-018-1498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-018-1498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T19:50:23Z","timestamp":1581969023000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-018-1498-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1007\/s00261-018-1498-z","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"20 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"TJZ, JLH, FTL, and SAW are paid consultants for Ethicon Inc. MGL receives grant support from Phillips and Ethicon Inc. FTL is on the board of directors of HistoSonics. The remaining authors have no relevant disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}